In Situ Hybridization Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott
- PerkinElmer, Inc.
- Leica Biosystems Nussloch GmbH
- F. Hoffman-La Roche Limited
- NeoGenomics Laboratories, Inc.
- Advanced Cell Diagnostics, Inc.
- BioView
- Agilent Technologies, Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Oxford Gene Technology IP Limited
- Bio-Techne Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of in situ hybridization is estimated at USD 1.84 Billion.
The global in situ hybridization market size was more than USD 1.73 Billion in 2025 and is anticipated to grow at a CAGR of over 7.3%, reaching USD 3.5 Billion revenue by 2035.
North America’s in situ hybridization market will dominate more than 45% share by 2035, fueled by rising healthcare spending and adoption of diagnostic technologies.
Key players in the market include Thermo Fisher Scientific Inc., Abbott, PerkinElmer, Inc., Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories, Inc., Advanced Cell Diagnostics, Inc., BioView, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Oxford Gene Technology IP Limited.
